These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 24293576)

  • 21. Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register.
    McErlane F; Foster HE; Davies R; Lunt M; Watson KD; Symmons DP; Hyrich KL
    Rheumatology (Oxford); 2013 Oct; 52(10):1905-13. PubMed ID: 23873820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study.
    Vastert SJ; de Jager W; Noordman BJ; Holzinger D; Kuis W; Prakken BJ; Wulffraat NM
    Arthritis Rheumatol; 2014 Apr; 66(4):1034-43. PubMed ID: 24757154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term quality of life and functional outcome of patients with juvenile idiopathic arthritis in the biologic era: a longitudinal follow-up study in the Dutch Arthritis and Biologicals in Children Register.
    Anink J; Prince FH; Dijkstra M; Otten MH; Twilt M; ten Cate R; Gorter SL; Koopman-Keemink Y; van Rossum MA; Hoppenreijs EP; van Suijlekom-Smit LW
    Rheumatology (Oxford); 2015 Nov; 54(11):1964-9. PubMed ID: 26078219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of patients with juvenile idiopathic arthritis (JIA) in a population-based cohort.
    Zamora-Legoff JA; Krause ML; Crowson CS; Muskardin TW; Mason T; Matteson EL
    Clin Rheumatol; 2016 Jun; 35(6):1493-9. PubMed ID: 26825065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biologic Switching Among Nonsystemic Juvenile Idiopathic Arthritis Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance Registry.
    Mannion ML; Xie F; Horton DB; Ringold S; Correll CK; Dennos A; Beukelman T;
    J Rheumatol; 2021 Aug; 48(8):1322-1329. PubMed ID: 32934124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Juvenile idiopathic arthritis--current and future therapies.
    Kahn P
    Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flares After Withdrawal of Biologic Therapies in Juvenile Idiopathic Arthritis: Clinical and Laboratory Correlates of Remission Duration.
    Simonini G; Ferrara G; Pontikaki I; Scoccimarro E; Giani T; Taddio A; Meroni PL; Cimaz R
    Arthritis Care Res (Hoboken); 2018 Jul; 70(7):1046-1051. PubMed ID: 28973842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High doses of infliximab in the management of juvenile idiopathic arthritis.
    Tambralli A; Beukelman T; Weiser P; Atkinson TP; Cron RQ; Stoll ML
    J Rheumatol; 2013 Oct; 40(10):1749-55. PubMed ID: 23950184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of tocilizumab on growth impairment in systemic juvenile idiopathic arthritis with long-term corticosteroid therapy.
    Miyamae T; Yokoya S; Yamanaka H; Yokota S
    Mod Rheumatol; 2014 Jul; 24(4):567-71. PubMed ID: 24252004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective study on 158 Thai patients with juvenile idiopathic arthritis followed in a single center over a 15-year period.
    Vilaiyuk S; Soponkanaporn S; Jaovisidha S; Benjaponpitak S; Manuyakorn W
    Int J Rheum Dis; 2016 Dec; 19(12):1342-1350. PubMed ID: 26176300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
    Quartier P; Taupin P; Bourdeaut F; Lemelle I; Pillet P; Bost M; Sibilia J; Koné-Paut I; Gandon-Laloum S; LeBideau M; Bader-Meunier B; Mouy R; Debré M; Landais P; Prieur AM
    Arthritis Rheum; 2003 Apr; 48(4):1093-101. PubMed ID: 12687553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth Failure in Children with Systemic Juvenile Idiopathic Arthritis and Prolonged Inflammation despite Treatment with Biologicals: Late Normalization of Height by Combined Hormonal Therapies.
    de Zegher F; Reynaert N; De Somer L; Wouters C; Roelants M
    Horm Res Paediatr; 2018; 90(5):337-343. PubMed ID: 29940586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids.
    Simon D; Fernando C; Czernichow P; Prieur AM
    J Rheumatol; 2002 Jun; 29(6):1296-300. PubMed ID: 12064849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis Cohort.
    Glerup M; Rypdal V; Arnstad ED; Ekelund M; Peltoniemi S; Aalto K; Rygg M; Toftedal P; Nielsen S; Fasth A; Berntson L; Nordal E; Herlin T;
    Arthritis Care Res (Hoboken); 2020 Apr; 72(4):507-516. PubMed ID: 30762291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era.
    Giancane G; Muratore V; Marzetti V; Quilis N; Benavente BS; Bagnasco F; Alongi A; Civino A; Quartulli L; Consolaro A; Ravelli A
    Arthritis Res Ther; 2019 Jul; 21(1):168. PubMed ID: 31287015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone increases final height in patients with juvenile idiopathic arthritis: data from a randomized controlled study.
    Bechtold S; Ripperger P; Dalla Pozza R; Bonfig W; Häfner R; Michels H; Schwarz HP
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3013-8. PubMed ID: 17535995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The frequency of infections in patients with juvenile idiopathic arthritis on biologic agents: 1-year prospective study.
    Aygun D; Sahin S; Adrovic A; Barut K; Cokugras H; Camcıoglu Y; Kasapcopur O
    Clin Rheumatol; 2019 Apr; 38(4):1025-1030. PubMed ID: 30448935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment.
    Nalbanti P; Kanakoudi-Tsakalidou F; Trachana M; Pratsidou-Gertsi P; Farmaki E; Bamidis P; Papachristou F
    Rheumatol Int; 2018 Jul; 38(7):1241-1250. PubMed ID: 29845429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current therapy of polyarticular forms of juvenile idiopathic arthritis].
    Hospach A; Rühlmann JM; Weller-Heinemann F
    Z Rheumatol; 2016 Apr; 75(3):284-91. PubMed ID: 27001055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and MRI outcome of cervical spine lesions in children with juvenile idiopathic arthritis treated with anti-TNFα drugs early in disease course.
    Ključevšek D; Emeršič N; Toplak N; Avčin T
    Pediatr Rheumatol Online J; 2017 May; 15(1):38. PubMed ID: 28506237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.